ArticleMolecular therapy oncolytics2021

Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis.

Su-Jie Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.